相似文献
1
Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis.
J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):356-60. doi: 10.1136/jnnp.56.4.356.
2
Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus.
Acta Neurol Scand. 1993 May;87(5):356-60. doi: 10.1111/j.1600-0404.1993.tb04117.x.
3
[Cerebrospinal fluid IgG and the blood-brain barrier in multiple sclerosis. A new viewpoint].
Nervenarzt. 1991 Feb;62(2):127-9.
4
Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis.
Arch Neurol. 1990 Jan;47(1):19-26. doi: 10.1001/archneur.1990.00530010027014.
5
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
Brain. 2015 Sep;138(Pt 9):2571-83. doi: 10.1093/brain/awv203. Epub 2015 Jul 17.
6
MRI as an outcome in multiple sclerosis clinical trials.
Neurology. 2009 Feb 24;72(8):705-11. doi: 10.1212/01.wnl.0000336916.38629.43. Epub 2008 Dec 10.
7
Multiple sclerosis: relations between MRI and CT findings, cerebrospinal fluid parameters and clinical features.
Clin Neurol Neurosurg. 1990;92(1):49-56. doi: 10.1016/0303-8467(90)90007-r.
8
Serum IgG to brain microvascular endothelial cells in multiple sclerosis.
J Neurol Sci. 1996 Nov;143(1-2):107-13. doi: 10.1016/s0022-510x(96)00184-0.
9
Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):446-51. doi: 10.1136/jnnp.63.4.446.
10
Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.
Ann Neurol. 1991 May;29(5):548-55. doi: 10.1002/ana.410290515.
引用本文的文献
1
Impairment of spinal CSF flow precedes immune cell infiltration in an active EAE model.
J Neuroinflammation. 2024 Oct 23;21(1):272. doi: 10.1186/s12974-024-03247-9.
2
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis.
Biomedicines. 2022 Jul 7;10(7):1629. doi: 10.3390/biomedicines10071629.
3
Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis.
Front Neurol. 2019 Feb 22;10:132. doi: 10.3389/fneur.2019.00132. eCollection 2019.
4
Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):446-51. doi: 10.1136/jnnp.63.4.446.
5
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis.
Brain Pathol. 1996 Jul;6(3):259-74. doi: 10.1111/j.1750-3639.1996.tb00854.x.
6
Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis.
Acta Neuropathol. 1995;90(3):228-38. doi: 10.1007/BF00296505.
7
Cerebrospinal fluid.
J Neurol Neurosurg Psychiatry. 1995 Oct;59(4):349-57. doi: 10.1136/jnnp.59.4.349.
本文引用的文献
1
FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.
Neurology. 1965 Jul;15:654-61. doi: 10.1212/wnl.15.7.654.
2
SERUM HAPTOGLOBIN CHANGES IN MULTIPLE SCLEROSIS.
Neurology. 1965 May;15:415-8. doi: 10.1212/wnl.15.5.415.
3
Haptoglobins in cerebrospinal fluid.
Clin Chim Acta. 1963 Mar;8:202-6. doi: 10.1016/0009-8981(63)90158-x.
4
The diagnostic value of the examination of the cerebrospinal fluid.
Postgrad Med J. 1952 Nov;28(325):587-91. doi: 10.1136/pgmj.28.325.587.
5
Characteristic protein fractions of cerebrospinal fluid disc electrophoretic analysis.
Brain Res. 1980 Sep 29;198(1):147-56. doi: 10.1016/0006-8993(80)90350-9.
6
Electrophoresis of CSF proteins.
Br J Hosp Med. 1982 Dec;28(6):600-8.
7
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Ann Neurol. 1983 Mar;13(3):227-31. doi: 10.1002/ana.410130302.
8
Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis.
Ann Neurol. 1984 Mar;15(3):257-63. doi: 10.1002/ana.410150309.
9
Impairment of blood-cerebrospinal fluid barrier in multiple sclerosis.
J Neurochem. 1983 Oct;41(4):1102-8. doi: 10.1111/j.1471-4159.1983.tb09058.x.
10
Polyacrylamide gel electrophoresis of spinal fluid proteins, neurological disorders.
Arch Neurol. 1966 Jan;14(1):64-72. doi: 10.1001/archneur.1966.00470070068008.
Zotero 插件